pharmadog

News

when

Latest
Archive

by source

All Sources
Sources Page

Jobs

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

made by humans and a good dog

home
jobs
news
search

calendar

29,103 catalysts · 9,600 approval · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma · 2,000 device recall

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

sort

soonest latest type sponsor alpha

from 2017-08-22×clear all

type

approval9,600
device 510k5,000
grant4,728
8k filing2,984
device pma2,000
device recall2,000

recall

1,126

device adverse event1,000

earnings572

phase 2 completion172

therapy area

Oncology148
Infectious Disease46
Cardiology37
Immunology35
Dermatology31
Pulmonology22
Women's Health19
Ophthalmology16
Pain15

Week of May 11, 2020

›May 14, 2020approval2278d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

›May 14, 2020approval2278d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

›May 15, 2020approval2277d agoOPDIVO (NIVOLUMAB) — FDA approvalnivolumab

Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION

full page →nivolumab →fda approvals ↗

›May 15, 2020approval2277d agoRUBRACA (RUCAPARIB CAMSYLATE) — FDA approvalrucaparib camsylate

Sponsor: PHARMAAND. Form: TABLET. Route: ORAL

full page →rucaparib camsylate →fda approvals ↗

Week of May 18, 2020

›May 18, 2020approval2274d agoTECENTRIQ (ATEZOLIZUMAB) — FDA approvalatezolizumab

Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION

full page →atezolizumab →fda approvals ↗

›May 19, 2020approval

Week of May 25, 2020

›May 25, 2020approval2267d agoVABOMERE (MEROPENEM) — FDA approvalHQ Speciality Pharma

Sponsor: REMPEX. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

›May 26, 2020approval

Week of Jun 1, 2020

›Jun 1, 2020approval2260d agoMAGNESIUM SULFATE — FDA approvalMAGNESIUM SULFATE

Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE. Route: INJECTION

full page →MAGNESIUM SULFATE →fda approvals ↗

›Jun 1, 2020approval

Week of Jun 8, 2020

›Jun 8, 2020approval2253d agoTOPAMAX SPRINKLE (TOPIRAMATE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Jun 8, 2020approval

Week of Jun 15, 2020

›Jun 15, 2020approval2246d agoZEPZELCA (LURBINECTEDIN) — FDA approvallurbinectedin

Sponsor: JAZZ. Form: POWDER. Route: INTRAVENOUS

full page →lurbinectedin →fda approvals ↗

›Jun 15, 2020approval

← prev

page 42 of 583

2273d ago

DEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

›May 19, 2020approval2273d agoDEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

›May 19, 2020approval2273d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

›May 21, 2020approval2271d agoDUOPA (CARBIDOPA) — FDA approvalcarbidopa

Sponsor: ABBVIE. Form: SUSPENSION. Route: ENTERAL

full page →carbidopa →fda approvals ↗

2266d ago

DUPIXENT (DUPILUMAB) — FDA approvaldupilumab

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION

full page →dupilumab →fda approvals ↗

›May 26, 2020approval2266d agoARTESUNATE — FDA approvalARTESUNATE

Sponsor: AMIVAS. Form: POWDER. Route: INTRAVENOUS

full page →ARTESUNATE →fda approvals ↗

›May 26, 2020approval2266d agoOPDIVO (NIVOLUMAB) — FDA approvalnivolumab

Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION

full page →nivolumab →fda approvals ↗

›May 27, 2020approval2265d agoOSELTAMIVIR PHOSPHATE — FDA approvalOSELTAMIVIR PHOSPHATE

Sponsor: AJANTA PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL

full page →OSELTAMIVIR PHOSPHATE →fda approvals ↗

›May 28, 2020approval2264d agoBUSPIRONE HYDROCHLORIDE — FDA approvalOxford Pharmaceuticals LLC

Sponsor: OXFORD PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›May 28, 2020approval2264d agoACTEMRA (TOCILIZUMAB) — FDA approvaltocilizumab

Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION

full page →tocilizumab →fda approvals ↗

›May 28, 2020approval2264d agoACTEMRA (TOCILIZUMAB) — FDA approvaltocilizumab

Sponsor: GENENTECH. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS

full page →tocilizumab →fda approvals ↗

›May 29, 2020approval2263d agoPALIPERIDONE — FDA approvalEskayef Pharmaceuticals Ltd

Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

›May 29, 2020approval2263d agoPALIPERIDONE — FDA approvalEskayef Pharmaceuticals Ltd

Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

›May 29, 2020approval2263d agoPALIPERIDONE — FDA approvalEskayef Pharmaceuticals Ltd

Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

›May 29, 2020approval2263d agoPALIPERIDONE — FDA approvalEskayef Pharmaceuticals Ltd

Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

›May 29, 2020approval2263d agoVENCLEXTA (VENETOCLAX) — FDA approvalvenetoclax

Sponsor: ABBVIE. Form: TABLET. Route: ORAL

full page →venetoclax →fda approvals ↗

›May 29, 2020approval2263d agoLORBRENA (LORLATINIB) — FDA approvallorlatinib

Sponsor: PFIZER. Form: TABLET. Route: ORAL

full page →lorlatinib →fda approvals ↗

›May 29, 2020approval2263d agoOXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: MIKART. Form: SOLUTION. Route: ORAL

full page →acetaminophen ER →fda approvals ↗

›May 29, 2020approval2263d agoORIAHNN (COPACKAGED) (ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE) — FDA approvalORIAHNN (COPACKAGED)

Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL

full page →ORIAHNN (COPACKAGED) →fda approvals ↗

›May 29, 2020approval2263d agoTECENTRIQ (ATEZOLIZUMAB) — FDA approvalatezolizumab

Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION

full page →atezolizumab →fda approvals ↗

›May 29, 2020approval2263d agoBUSPIRONE HYDROCHLORIDE — FDA approvalBUSPIRONE HYDROCHLORIDE

Sponsor: RISING. Form: TABLET. Route: ORAL

full page →BUSPIRONE HYDROCHLORIDE →fda approvals ↗

2260d ago

TREMFYA (GUSELKUMAB) — FDA approvalguselkumab

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →guselkumab →fda approvals ↗

›Jun 2, 2020approval2259d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

›Jun 3, 2020approval2258d agoYONDELIS (TRABECTEDIN) — FDA approvalJOHNSON & JOHNSON

Sponsor: JANSSEN PRODS. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

›Jun 4, 2020approval2257d agoRECARBRIO (CILASTATIN SODIUM) — FDA approval(cilastatin sodium + imipenem + relebactam)

Sponsor: MSD MERCK CO. Form: POWDER. Route: INTRAVENOUS

full page →(cilastatin sodium + imipenem + relebactam) →fda approvals ↗

›Jun 5, 2020approval2256d agoCAPRELSA (VANDETANIB) — FDA approvalvandetanib

Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL

full page →vandetanib →fda approvals ↗

›Jun 5, 2020approval2256d agoPRIFTIN (RIFAPENTINE) — FDA approvalrifapentine

Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

full page →rifapentine →fda approvals ↗

›Jun 5, 2020approval2256d agoPRIFTIN (RIFAPENTINE) — FDA approvalrifapentine

Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

full page →rifapentine →fda approvals ↗

›Jun 5, 2020approval2256d agoIMFINZI (DURVALUMAB) — FDA approvalASTRAZENECA PLC

Sponsor: ASTRAZENECA UK LTD. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

2253d ago

TOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jun 8, 2020approval2253d agoBINOSTO (ALENDRONATE SODIUM) — FDA approvalOrganon & Co.

Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL

full page →fda approvals ↗

›Jun 9, 2020approval2252d agoSODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (SODIUM CHLORIDE) — FDA approvalRevalesio Corp

Sponsor: LABORATORIOS GRIFOLS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

›Jun 9, 2020approval2252d agoPRIFTIN (RIFAPENTINE) — FDA approvalrifapentine

Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

full page →rifapentine →fda approvals ↗

›Jun 10, 2020approval2251d agoOPDIVO (NIVOLUMAB) — FDA approvalnivolumab

Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION

full page →nivolumab →fda approvals ↗

›Jun 10, 2020approval2251d agoFLUOXETINE HYDROCHLORIDE — FDA approvalFLUOXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →FLUOXETINE HYDROCHLORIDE →fda approvals ↗

›Jun 11, 2020approval2250d agoUPLIZNA (INEBILIZUMAB-CDON) — FDA approvalHorizon Therapeutics USA Inc

Sponsor: VIELA BIO. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

›Jun 12, 2020approval2249d agoVENCLEXTA (VENETOCLAX) — FDA approvalvenetoclax

Sponsor: ABBVIE. Form: TABLET. Route: ORAL

full page →venetoclax →fda approvals ↗

›Jun 12, 2020approval2249d agoTIVICAY (DOLUTEGRAVIR SODIUM) — FDA approvalViiV Healthcare Company

Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jun 12, 2020approval2249d agoTIVICAY PD (DOLUTEGRAVIR SODIUM) — FDA approvalViiV Healthcare Company

Sponsor: VIIV HLTHCARE. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

2246d ago

CAPRELSA (VANDETANIB) — FDA approvalvandetanib

Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL

full page →vandetanib →fda approvals ↗

›Jun 15, 2020approval2246d agoSUBLOCADE (BUPRENORPHINE) — FDA approvalbuprenorphine LA

Sponsor: INDIVIOR. Form: SOLUTION, EXTENDED RELEASE. Route: SUBCUTANEOUS

full page →buprenorphine LA →fda approvals ↗

$BMY64.72+0.89%

$JAZZ256.56-0.04%

$REGN784.36+1.59%

$ABBV246.04+0.89%

$PFE26.76+2.14%

$BMY64.72+0.89%

$ABBV246.04+0.89%

$JNJ259.24+0.88%

$MRK128.58+0.16%

$AZN161.42+0.88%

$ABBV246.04+0.89%

$OGN13.60+0.37%

$INDV38.82+0.39%

$BMY64.72+0.89%